A phase 1/2 study of EG-70 (detalimogene voraplasmid) intravesical monotherapy for patients with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ

被引：0
|
作者：
Bryce, Richard
Tosone, Christine
Sullivan, James C.
Linback, Tammy
Steinberg, Gary D.
机构：
[1] EnGene Inc, Boston, MA USA
[2] RUSH Univ, Med Coll, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4626
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I/II study of EG-70 (detalimogene voraplasmid) intravesical monotherapy for patients (pts) with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS)
    Palou, J.
    Marcq, G.
    Steinberg, G.
    Toscone, C.
    Sullivan, J.
    Linback, T.
    Pruthi, R.
    Bryce, R.
    Brown, G.
    ANNALS OF ONCOLOGY, 2024, 35 : S1165 - S1165
  • [2] A phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer (NMIBC).
    Chang, Sam S.
    Dickstein, Rian J.
    Jayram, Gautam
    Shore, Neal D.
    Liu, Jen-Jane
    Lotan, Yair
    Satkunasivam, Raj
    Schuckman, Anne K.
    Steinberg, Gary D.
    Taylor, John R.
    Linback, Tammy
    Pruthi, Raj
    Sullivan, James C.
    Tosone, Christine
    Kamat, Ashish M.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : TPS886 - TPS886
  • [3] LEGEND, A PHASE 1/2 STUDY OF DETALIMOGENE VORAPLASMID (EG-70) INTRAVESICAL MONOTHERAPY DEMONSTRATED CLINICAL RESPONSES IN BCG-UNRESPONSIVE NMIBC PATIENTS WITH CIS
    Gary, Steinberg
    Susan, Kolata
    Yair, Lotan
    Christine, Tosone
    Rosemary, Mazanet
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S48 - S48
  • [4] EG-70 (detalimogene voraplasmid), a novel, non-viral intravesical gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: Preclinical characterization and translation into the clinic
    Goulet, Marie-Line
    Dauphinee, Shauna M.
    Veilleux, Daniel
    Louis, Kristine S.
    Lazure, David
    Stevenson, Sarah
    Bilimoria, Darius
    Zamzameer, Fazmina
    Chen, Ximin
    Sublemontier, Sebastien
    Amirkhani, Sahar
    Fleet, Carlos
    Bryce, Richard
    Bui, Matthew
    Joshi, Shreyas
    Kalota, Susan J.
    Cheung, Anthony
    Sullivan, James
    CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [5] Clinical results of a phase 1 study of intravesical EG-70 in patients with BCG-unresponsive NMIBC.
    Steinberg, Gary D.
    Kalota, Susan J.
    Lotan, Yair
    Warner, Loraine
    Dauphinee, Shauna
    Mazanet, Rosemary
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [6] HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    de Jong, Joep
    Hendricksen, Kees
    Rosier, Marloes
    Boormans, Joost
    Mostafid, Hugh
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1234 - E1235
  • [7] Current advances in BCG-unresponsive non-muscle invasive bladder cancer
    Tse, Jennifer
    Singla, Nirmish
    Ghandour, Rashed
    Lotan, Yair
    Margulis, Vitaly
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (09) : 757 - 770
  • [8] PHASE 3 RESULTS OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Shore, Neal
    O'Donnell, Michael
    Keane, Thomas
    Jewett, Michael A. S.
    Kulkarni, Girish S.
    Dickstein, Rian
    Wolk, Fred
    Dunshee, Curtis
    Belkoff, Laurence
    Dillon, Rachelle L.
    Cizeau, Jeannick
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2020, 203 : E72 - E72
  • [9] COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Joffe, Benjamin I.
    Christin, John R.
    Le Coz, Clementine
    Pak, Jamie S.
    Laplaca, Caroline
    Reyes, Helena Vila
    DeCastro, G. Joel
    Anderson, Christopher B.
    Abate-Shen, Cory
    McKiernan, James M.
    Lenis, Andrew T.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E247 - E248
  • [10] New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
    Asimakopoulos, Anastasios D.
    Kochergin, Maxim
    Colalillo, Gaia
    Fahmy, Omar
    Hassan, Fahmy
    Renninger, Markus
    Gallioli, Andrea
    Gavrilov, Pavel
    Gakis, Georgios
    BLADDER CANCER, 2023, 9 (03) : 237 - 251
12345